November 4th, 2026Why Impurity Deficiencies Keep Repeating: AAPS PharmSci 360 2026Impurity deficiencies in submissions are remarkably consistent. Subathra Ramamoorthy, Veranova, explains how to catch them before agency filing.Read more
November 2nd, 2026Potent APIs Amplify Carryover Risk: AAPS PharmSci 360 2026Subathra Ramamoorthy, Veranova, on how forced degradation and trace impurity profiling in potent APIs shape regulator-ready analytical methods.Read more
October 30th, 2026Late-Phase Impurities Need Reference Standards: AAPS PharmSci 360 2026Subathra Ramamoorthy, Veranova, on when to escalate to structural elucidation and pair orthogonal techniques when characterizing an impurity.Read more
October 30th, 2026AI Validation Demands Version Control: AAPS PharmSci 360 2026Manish Baviskar, Hubot CDMO, on ALCOA++ data integrity, model version change control, continuous monitoring, and human sign-off.Read more
October 29th, 2026Why AI Model Updates Need Change Control: AAPS PharmSci 360 2026Manish Baviskar, Hubot CDMO, explains which AI skills validation engineers need first and why AI model updates must go through GMP change control.Read more
October 29th, 20261074 Revision Needs Formulator Feedback: AAPS PharmSci 360 2026Ron Filler, Drug Development Consultants, explains how USP's 1074 revision brings human-relevant safety science to formulators and excipient makers.Read more
October 29th, 2026AAPS PharmSci 360 2026: Spray Drying and ASDNitin Kumar Swarnakar, PhD, global application lab manager at BASF, talks about spray drying for drying amorphous solid dispersions and Raman spectroscopy’s role as a quantitative analytical tool.Read more
October 28th, 2026USP 1074 Revises Excipient Safety: AAPS PharmSci 360 2026Ron Filler, Drug Development Consultants, explains how USP's 1074 revision brings human-relevant safety science to formulators and excipient makers.Read more